Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Primary Culture of Breast Cancer: A Model System for Epithelial-Mesenchymal Transition and Cancer Stem Cells

TAKAHITO NISHIKATA, MAMI ISHIKAWA, TETSUHIRO MATSUYAMA, KAZUHIKO TAKAMATSU, TOSIYUKI FUKUHARA and YUTAKA KONISHI
Anticancer Research July 2013, 33 (7) 2867-2873;
TAKAHITO NISHIKATA
1Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, Japan
2Frontier Institute for Biomolecular Engineering Research (FIBER), Konan University, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nisikata{at}konan-u.ac.jp
MAMI ISHIKAWA
1Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TETSUHIRO MATSUYAMA
1Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUHIKO TAKAMATSU
1Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, Japan
3Drug Safety Research Laboratories, Astellas Pharma Inc., Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSIYUKI FUKUHARA
4Kobe Urban Breast Clinic, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUTAKA KONISHI
4Kobe Urban Breast Clinic, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: A novel model system to study the cellular, molecular, and genetic characteristics of breast cancer stem cells is needed. Personalized prognostic models are indispensable for assessing the effect of so-called tailor-made adjuvant therapy. Materials and Methods: Surgically-extirpated tissues were dispersed with Dispase and cultured in commonly used medium. The expression of tumor markers was detected with immunohistochemistry, and gene expression profiles of tissues and cells were analyzed using the Agilent Human Microarray. Results: We established a primary culture, which exhibited mesenchymal morphology. The gene expression profile of the primary culture revealed that the cells underwent epithelial-mesenchymal transition and had cancer stem cell properties. Conclusion: A primary culture of breast cancer cells can be easily established and could be used for studying breast cancer stem cells and assessing treatment of a patient.

  • EMT
  • Epithelial-mesenchymal transition
  • CSC
  • cancer stem cell
  • CD44
  • musashi
  • cadherin

Metastasis control is an important issue for treating many types of cancer, including breast cancer. Establishment of a primary culture of cells from surgically-extirpated tumor tissue is a promising method for better designing suitable treatments for individual patients (1). Moreover, cancer stem cells (CSCs) are thought to be important targets for cancer therapy (2, 3). Previous researchers have established a primary culture of breast cancer cells with stem cell properties (4, 5). This system represents a suitable in vitro model for developing therapeutic strategies aimed at eradicating the CSCs in breast cancer.

In this study, we established primary cultured cells from a surgically-extirpated tumor. Comprehensive characterization of normal and malignant tissues, a normal breast epithelial cell line, and the primary cell culture with immunohistochemistry and gene chip analysis revealed that the established primary culture underwent epithelial-mesenchymal transition (EMT) and also had properties of CSCs. These characteristic features represent a good model system for studying breast cancer stem cells (BCSCs). Moreover, we used this method as a model system for evaluating the effects of hyperthermia as a possible therapeutic treatment. This system may help predict response-to-treatment.

Materials and Methods

Tissue samples. The normal and malignant tissues were extra portions of surgically-extirpated scirrhous carcinoma of the female breast and were obtained at the Kobe Urban Breast Clinic (Kobe, Japan). The patient was 55 years old and received neoadjuvant systemic chemotherapy with letrozole, tegafur/gimeracil/oteracil, and cyclophosphamide/docetaxel. The patient provided written informed consent, and this study was approved by the Human Ethics Committee of Konan University (11-02).

Cells and cell culture. The chemically-transformed normal mammary gland breast epithelial cell line CRL-8798 was obtained from the American Type Culture Collection (Manassas, VA, USA), and human dermal fibroblast cells (HDF) were purchased from Summit Pharmaceutical (Tokyo, Japan). The breast tissue was digested overnight at 37°C with 1,000 pU/ml Dispase II (Eidia, Tokyo, Japan) or plated on a Petri dish and cultured for transmigration. The obtained primary cells were cultured in two different media: MCF medium [Earle's Eagle's Minimum Essential Medium, 1 mM sodium pyruvate, 10 μg/ml bovine insulin, 1× non-essential amino acids (Sigma, St. Louis, MO, USA), 10% Fetal Bovine Serum (EuroClone, Milano, Italy)] and a commercially available medium [designated ME medium in this study: Normal Human Mammary Epithelial Cell System (CC-3150; Lonza, Walkersville, MD, USA)].

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Expression profiles of characteristic genes in MCKH cells.

Histochemistry. The extirpated tissues were fixed with 4% formalin and embedded in paraffin. Cultured cells were grown on coverslips and fixed with 4% formalin followed by fixation in 100% methanol.

Antibodies. The antibodies for the selected tumor markers were as follows: anti-estrogen receptor (ER) (Ab-14; Thermo Scientific, Cheshire, UK), anti-cytokeratin-19 (CK19) (BioLegend, San Diego, CA, USA), anti-CD66/carcinoembryonic antigen (CEA) (CEACAM5; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-mucin 1 (MUC1; Abcam, Cambridge, UK), anti-breast cancer antigen 225 (BCA225; Abcam), anti-tumor associated glycoprotein 72 (TAG72; Abcam), anti-cancer antigen 125 (CA125; Abcam), anti-beta-tubulin (T5293; Sigma), and fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (American Qualex, San Clemente, CA, USA).

Gene expression profiles. The total RNAs of extirpated tissues and cultured cells were extracted with RNeasy (Qiagen, Tokyo, Japan) according to the manufacturer's instructions. The gene expression profiles were analyzed with Hokkaido System Science (Sapporo, Japan) using the SurePrint G3 Human GE Microarray Kit 8X60k (Agilent, Santa Clara, CA, USA). These data were compared to data obtained from normal tissue adjacent to the tumor, extirpated from the same patient.

Heat-shock experiment and semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR). Cells were plated onto 35-mm culture dishes (2.5×105 cells/dish), and heat shocked by incubation at 40°C for 1 h, 43°C for 10 min, or 43°C for 1 h. Heat shock was carried out three times. The cell survival rate was measured with the 3-(4, 5-dimethylthiazolyl-2)–2,5-diphenyltetrazolium bromide (MTT) method. Total RNAs were extracted 1 h after the heat shock, and cDNAs were obtained with reverse transcription. The PCR program was 94°C for 2 min, followed by 19 cycles of 94°C for 1 min, 56°C for 1 min, and 72°C for 1 min, followed by a final cycle of 72°C for 4 min. Under these conditions, amplification was not saturated. The amounts of mRNAs were normalized to the amount of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA, and the expression profiles are shown as the ratio to that of control cells, which were cultured at 37°C.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Expression profiles of tumor antigens.

Results

Establishment of primary cultures from the breast tumor. Primary cultures were established using two different methods: a tissue-fragment culture and a dispersed cell culture. Cells were grown in two different media, MCF and ME medium. In this study, we used Dispase II for cell dispersal and obtained primary cultures from all plated dishes. On the other hand, the tissue-fragment culture method was less effective for establishing a primary culture. We found that the MCF medium was more suitable for establishing a primary culture from the breast tumor.

Both the tissue-fragment culture and the dispersed cell culture methods produced similar populations of primary cultured cells. At the initial phase of cell spreading, morphological heterogeneity was observed in which both a long, flattened mesenchymal phenotype and a columnar epithelial phenotype were present. However, several passages later, all primary cultures exhibited a uniform mesenchymal phenotype. In this study, these cell lines were deemed equivalent and were designated as MCKH (primary culture of mammary carcinoma from KH) primary cultured cells.

The primary culture recapitulated some original tumor characteristics but also exhibited a characteristic expression pattern including stemness. To characterize the primary cultured cells, we carried out gene expression analyses and performed immunocytochemical detection of selected tumor markers in the normal and malignant tissues, and CRL-8798 and MCKH cells. The tumor of this patient was originally characterized in a clinical test as ER/progesterone receptor-positive, human epidermal growth factor receptor-2-negative. In addition, the levels of CK19 in the patient's peripheral blood (3.7 ng/ml) were slightly higher than the normal levels, whereas levels of B-type natriuretic peptide (BNP), CA125, CA19-9, CEA, and squamous cell carcinoma antigen (SCC) were normal.

Table I summarizes the gene expression analyses. The RNA expressions of ER, progesterone receptor, CK19, MUC1, and some other genes were dramatically lower in MCKH cells compared to the malignant tissue. Some tumor markers [breast cancer anti-estrogen resistance 1 (BCAR1) and breast carcinoma amplified sequence 4 (BCAS4)], some genes in the NOTCH and WNT signaling pathways [NOTCH1, delta-like (DLL) 3, and WNT1], and a keratin gene (KRT12) maintained a normal expression pattern.

Immunocytochemical analyses showed that ER, CK19, CD66/CEA, MUC1, BCA225, and TAG72 were clearly expressed in the extirpated malignant tissue, whereas their expression was lost in the primary culture (Table II, Figure 1). Only CK19 was expressed faintly in early passages of the primary culture (Figure 1J and Table II). These observations suggest down-regulation of these genes during establishment of the primary culture.

Recently, CSCs have become an intriguing cell population within the tumor (5). Markers for human BCSCs are CD44+ and CD24−/low (6). As shown in Table I, MCKH cells lost CD24 expression and had up-regulated CD44 expression. Moreover, p21 (CIP1) and musashi homolog 1 (MSI1) have also been suggested to be putative stem cell markers in the breast (7). In MCKH cells, p21 was up-regulated more than five-fold than in the malignant tissue, and MSI1 was up-regulated more than 7-fold. All of these changes in the expression of stemness marker genes clearly show the stem cell characteristics of MCKH cells.

Moreover, the expression of a metallopeptidase gene (matrix metallopeptidase 1, MMP1) was dramatically increased (more than 2,800-fold) in MCKH cells, suggesting invasive characteristics of MCKH cells. CD133 expression may be related to metastatic localization in the bone (8). Slight up-regulation of CD133 in MCKH cells suggests high invasiveness into bone. In fact, bone metastasis was found six months after surgery in the patient who donated the tissue. Loss or reduced retinoblastoma expression is seen in high-grade breast adenocarcinomas (9), but no significant change in retinoblastoma gene expression was observed in MCKH cells.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Immunocytochemical detection of some tumor markers. A-H: Histochemistry of malignant tissue (A-D) and normal tissue (E-H). Sections were stained with hematoxylin and eosin (A and E), or immunohistochemically stained for cytokeratin-19 (CK19; B and F), mucin-1 (MUC1; C and G), and breast cancer antigen 225 (BCA225; D and H). Immunostained tissues were double stained with DAPI (2 μg/ml). Mammary ducts were rich in nuclei (F-H) and negative for the proteins examined. I-L: Primary cultured MCKH cells were photographed under phase-contrast microscopy (I) or immunohistochemically stained for CK19 (J and K) and tubulin (L). CK19 staining was positive in early-passage cells (J: population doubling level=1.68) and negative in aged cells (K: population doubling level=9.43). Scale bar=100 μm.

Primary cell culture exhibited the EMT phenotype. EMT is characterized by down-regulation of epithelial proteins including E-cadherin, epithelial cytokeratins (KRT8, KRT18, and KRT19), junctional adhesion molecules including occludins (OCLN), claudins (CLDN), and desmoplakin (DSP); and by up-regulation of mesenchymal proteins including vimentin (VIM), fascin-1 (FSCN), α-smooth muscle actin (ACTA2), N-cadherin (CDH2), cadherin-11 (CDH11), TGFβ-1 (TGFB1), and transcription factors related to cadherin gene expression including forkhead box C1 and C2 (FOXC1 and -2), goosecoid homeobox (GSC), snail homolog 1 and 2 (SNAI1 and -2), E12/E47 (TCF3), twist homolog 1 and 2 (TWIST1 and -2), and Zinc finger E-box binding homeobox 1 and 2 (ZEB1 and -2) (10).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Survival rate and heat shock protein gene expression after heat shock treatment. A: Relative viability 24 h after heat-shock. After heat shock at 43°C for 1 h, the difference between CRL-8798 and MCKH cells was significant (*p=0.036). For the MCKH cells, the difference between heat shock at 43°C for 10 min and 43°C for 1 h was also significant (**p=0.039). Significant differences were calculated with Student's t-test. B-D: Relative expression of heat-shock protein genes, 1 h after heat shock in HDF (B), CRL-8798 (C), and MCKH (D) cells.

As shown in Table III, MCKH cells exhibited down-regulation of epithelial markers and up-regulation of mesenchymal markers. In particular, E-cadherin was down-regulated 400-fold, and N-cadherin almost 200-fold compared to those in malignant tissue. These changes were not seen with CRL-8798 cells. Moreover, both CLDN genes were dramatically reduced, and ACTA2 and several transcription factors (SNAI1, SNAI2, and TWIST2) were increased by more than 4 times. These data strongly suggested the presence of EMT in MCKH cells.

Primary culture as an assay system for adjuvant treatment. Because MCKH cells retained some original tumor characteristics, we heat-shocked the MCKH cells to examine the usefulness of this model system for testing possible treatments for the patient. As shown in Figure 2A, although more than 50% of CRL-8798 cells died after heat shock at 43°C for 1 h, about 80% of HDF and MCKH cells survived after the same heat shock. HDF cells highly-overexpressed heat-shock protein (HSP)70, and this overexpression was present even after the 40°C heat shock (Figure 2C). In MCKH cells, in addition to overexpression of HSP70, all HSP genes examined in this experiment were overexpressed (Figure 2D) compared to the CRL-8798 cells (Figure 2B). This overall overexpression of HSP genes suggests resistance by MCKH cells to heat shock. Thus, the MCKH model system shows that heat shock may only be minimally effective in treating this patient.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Expression profiles of the epithelial-mesenchymal transition (EMT)-related genes in MCKH cells.

Discussion

In this study, the most suitable method for establishing a primary culture from a surgically-extirpated breast tumor was the dispersed cell culture method using Dispase. MCKH cells exhibited EMT, which may represent the metastatic state of this tumor. As EMT is thought to be a crucial event for carcinoma progression, basic studies of EMT using model systems are still important for understanding how to control the metastatic progression of tumors (1).

The other important feature of MCKH cells is their stemness. CSCs exist within many types of cancer and are thought to play pivotal roles in both tumor initiation and maintenance of tumor growth (11). However, the origin of these CSCs remains unknown. Two hypotheses have been proposed suggesting that CSCs originate from normal tissue stem cells or arise from differentiated cancer cells through EMT (12). MCKH cells clearly exhibited both EMT and stemness, strongly suggesting a close relationship between EMT and CSCs.

BCSCs have been well-studied. For example, Ponti et al. established CD44+/CD24low BCSCs (4), which can be propagated in vitro as non-adherent mammospheres. Li et al. carried out proteomic analyses using mammospheres as a model system (13). Although we could not culture MCKH cells as mammospheres or demonstrate their tumorigenic activity, primary culture of breast cancer cells with a mesenchymal phenotype and stemness, as was seen with MCKH cells, is a unique in vitro culture system.

Some reports also established a cultured cell line from immortalized MDA-MB453 human breast cancer cells (14) and primary culture of breast cancer (1), which display CSC and EMT characteristics, respectively. These two reports analyzed the expression of only a limited number of genes. In our experiment, comprehensive analysis of gene expression was used to compare the four closely related types of tissues and cells (MCKH cells, CRL-8798 cells, malignant breast tumor, and normal breast tissue). The large amount of data generated in this study will provide accurate information about MCKH cells and will likely make these cells a good experimental model for analyzing the mechanisms of EMT and the maintenance and differentiation of CSCs. Understanding the cellular, molecular, and genetic mechanisms of EMT, and the cellular, molecular, and genetic characteristics of CSCs using a primary culture model system such as MCKH cells may provide potential therapeutic targets for treating the disease.

In this study, using MCKH cells as a model system, we assessed the effects of hyperthermia. MCKH cells were relatively resistant to heat shock, which may be due to overexpression of HSPs, but these data also suggest that prolonged hyperthermia may favorably affect cancer regression. On the other hand, resistance to high temperature supports the idea that MCKH cells have stem cell properties.

Acknowledgements

This work was partly supported by Grants-in-Aid for Scientific Research and the “Core Research” project (2009-2014) from the Ministry of Education, Culture, Sports, Science and Technology (Japan).

Footnotes

  • This article is freely accessible online.

  • Received April 4, 2013.
  • Revision received June 1, 2013.
  • Accepted June 3, 2013.
  • Copyright© 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Minafra L,
    2. Norata R,
    3. Bravatà V,
    4. Viola M,
    5. Lupo C,
    6. Gelfi C,
    7. Messa C
    : Unmasking epithelial-mesenchymal transition in a breast cancer primary culture. BMC Res Notes 5: 343, 2012.
    OpenUrlPubMed
  2. ↵
    1. Lapidot T,
    2. Sirard C,
    3. Vormoor J,
    4. Murdoch B,
    5. Hoang T,
    6. Caceres-Cortes J,
    7. Minden M,
    8. Paterson B,
    9. Caligiuri MA,
    10. Dick JE
    : A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648, 1994.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Kato K
    : Endometrial Cancer Stem Cells: A new target for cancer therapy. Anticancer Res 32: 2283-2293, 2012.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Ponti D,
    2. Costa A,
    3. Zaffaroni N,
    4. Pratesi G,
    5. Petrangolini G,
    6. Coradini D,
    7. Pilotti S,
    8. Pierotti MA,
    9. Daidone MG
    : Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511, 2005.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Pardal R,
    2. Clarke MF,
    3. Morrison SJ
    : Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3: 895-902, 2003.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Al-Hajj M,
    2. Wicha MS,
    3. Benito-Hernandez A,
    4. Morrison SJ,
    5. Clarke MF
    : Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Clarke RB,
    2. Spence K,
    3. Anderson E,
    4. Howell A,
    5. Okano H,
    6. Potten CS
    : A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 15: 443-456, 2005.
    OpenUrl
  8. ↵
    1. Ieni A,
    2. Giuffre G,
    3. Adamo V,
    4. Tuccari G
    : Prognostic impact of CD133 immunoexpression in node-negative invasive breast carcinomas. Anticancer Res 31: 1315-1320, 2011.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Arima Y,
    2. Inoue Y,
    3. Shibata T,
    4. Hayashi H,
    5. Nagano O,
    6. Saya H,
    7. Taya Y
    : Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Res 68: 5104-5112, 2008.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Tomaskovic-Crook E,
    2. Thompson EW,
    3. Thiery JP
    : Epithelial-to-mesenchymal transition and breast cancer. Breast Cancer Res 11: 213, 2009.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Vermeulen L,
    2. Sprick MR,
    3. Kemper K,
    4. Stassi G,
    5. Medema JP
    : Cancer stem cells – old concepts, new insights. Cell Death Differ 15: 947-958, 2008.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Morel AP,
    2. Lievre M,
    3. Thomas C,
    4. Hinkal G,
    5. Ansieau S,
    6. Puisieux A
    : Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3: e2888, 2008.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Li G,
    2. Zhao F,
    3. Cui Y
    : Proteomics using mammospheres as a model system to identify proteins deregulated in breast cancer stem cells. Curr Mol Med 13: 459-463, 2013.
    OpenUrlPubMed
  14. ↵
    1. Yoo YD,
    2. Han DH,
    3. Jang JM,
    4. Zakrzewska A,
    5. Kim SY,
    6. Choi CY,
    7. Lee YJ,
    8. Kwon YT
    : Molecular characteristics of cancer stem-like cells derived from human breast cancer cells. Anticancer Res 33: 763-777, 2013.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 33, Issue 7
July 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Primary Culture of Breast Cancer: A Model System for Epithelial-Mesenchymal Transition and Cancer Stem Cells
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Primary Culture of Breast Cancer: A Model System for Epithelial-Mesenchymal Transition and Cancer Stem Cells
TAKAHITO NISHIKATA, MAMI ISHIKAWA, TETSUHIRO MATSUYAMA, KAZUHIKO TAKAMATSU, TOSIYUKI FUKUHARA, YUTAKA KONISHI
Anticancer Research Jul 2013, 33 (7) 2867-2873;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Primary Culture of Breast Cancer: A Model System for Epithelial-Mesenchymal Transition and Cancer Stem Cells
TAKAHITO NISHIKATA, MAMI ISHIKAWA, TETSUHIRO MATSUYAMA, KAZUHIKO TAKAMATSU, TOSIYUKI FUKUHARA, YUTAKA KONISHI
Anticancer Research Jul 2013, 33 (7) 2867-2873;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Gene Expression Profiling of Epithelial-Mesenchymal Transition in Primary Breast Cancer Cell Culture
  • Google Scholar

More in this TOC Section

  • Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma
  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
Show more Experimental Studies

Keywords

  • EMT
  • epithelial-mesenchymal transition
  • CSC
  • cancer stem cell
  • CD44
  • musashi
  • cadherin
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire